Market Place
Sourcing Support
MiNK Therapeutics Reports Phase II Immune Data
17 Apr 2026 //
GLOBENEWSWIRE
MiNK Therapeutics, MSK Present agenT-797 Combo Data at AACR 2026
03 Apr 2026 //
GLOBENEWSWIRE
MiNK Therapeutics to Present iNKT Cell Data at ASGCT 2026
02 Apr 2026 //
GLOBENEWSWIRE
MiNK Therapeutics Gets Abstract Accepted at ATS 2026 Conference
01 Apr 2026 //
GLOBENEWSWIRE
MiNK Therapeutics: Strong 2025 Results, Advances Phase 2 Result
31 Mar 2026 //
GLOBENEWSWIRE
Mink Therapeutics To Present 2025 Financials, iNKT Cell Programs
17 Mar 2026 //
GLOBENEWSWIRE
C-Further Reveals Initial Pediatric Oncology Therapeutic Programs
10 Mar 2026 //
PHARMIWEB
MiNK Therapeutics Announces Collaboration with C-Further
10 Mar 2026 //
GLOBENEWSWIRE
MiNK Launches Phase 1 AGENT-797 Trial for GVHD
08 Jan 2026 //
GLOBENEWSWIRE
Mink Therapeutics Reveals Mink-215`s Strong Anti-Tumor Activity
20 Nov 2025 //
GLOBENEWSWIRE
Mink Therapeutics Reveals Allo-Inkt Cell Therapy Agent-797
07 Nov 2025 //
GLOBENEWSWIRE
Mink Therapeutics to Unveil Agent-797 Data at SITC Conference
30 Oct 2025 //
GLOBENEWSWIRE
Mink Pharma Appoints Colonel (ret.) John B. Holcomb To Board
29 Sep 2025 //
GLOBENEWSWIRE
Mink Pharma Appoints Dr. Terese Hammond to Advance iNKT Pipeline
18 Sep 2025 //
GLOBENEWSWIRE
MiNK Highlights iNKT Cells` Role in Solid Tumor Cell Therapy
15 Jul 2025 //
GLOBENEWSWIRE
MiNK’s iNKT Cell Therapy Achieves Remission in Testicular Cancer
11 Jul 2025 //
GLOBENEWSWIRE
MiNK Therapeutics Reports Q1 2025 Results and Progress
15 May 2025 //
GLOBENEWSWIRE
MiNK Therapeutics Presents Phase 2 Data on AgenT-797
12 Feb 2025 //
GLOBENEWSWIRE
MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer
18 Dec 2024 //
GLOBENEWSWIRE
MiNK Therapeutics to Provide Corporate Update & Q3 Financial Report
11 Nov 2024 //
GLOBENEWSWIRE
MiNK’s iNKT Cell Therapy Shows Promise at SITC 2024
07 Nov 2024 //
GLOBENEWSWIRE
MiNK Therapeutics Appoints Dr. Robert Kadlec to Board
31 Oct 2024 //
GLOBENEWSWIRE
MiNK And Autonomous Partner On Metastatic Tumor Therapies
08 Oct 2024 //
GLOBENEWSWIRE
MiNK Presents AgenT-797 Activity In Severe ARDS At ATS
22 May 2024 //
GLOBENEWSWIRE
MiNK Announces Promising Preclinical Activity of MiNK-215 at AACR
08 Apr 2024 //
GLOBENEWSWIRE
MiNK Announces Preclinical Data Showcasing Activity of MiNK-215
06 Mar 2024 //
GLOBENEWSWIRE
MiNK™s AgenT-797 Offers New Hope in Overcoming ICI Resistance
30 Jan 2024 //
GLOBENEWSWIRE
MiNK`s Novel FAP-CAR-iNKT Presented at ASGCT
18 May 2023 //
GLOBENEWSWIRE
MiNK to Present Data of allo-iNKT Cell Therapy in Solid Tumors
15 Mar 2023 //
GLOBENEWSWIRE
